Related by context. Frequent words. (Click for all words.) 66 including nutritionals devices 64 NASDAQ CRXL 64 bio therapeutics 63 Novelos Therapeutics Inc. 63 CONTAINS FORWARD LOOKING STATEMENTS 63 commercializing therapeutic 62 THE ISSUER IS AUTHORITATIVE 62 CONTAIN FORWARD LOOKING STATEMENTS 62 PINNACLEDIGEST.COM S PAST PERFORMANCE 62 therapies Biogen Idec 61 Pluristem Therapeutics Inc. 61 Cerus Corporation 61 Crucell NV Euronext 61 Advancing Wellness 61 ImmuneRegen BioSciences Inc. 61 SANUWAVE Health 60 Tissue Repair Company 60 BELIEFS PLANS EXPECTATIONS AND 60 please visit http:/www.supergen.com 60 SAFE HARBOR PROVISIONS OF 60 Inc Therapeutic Competitors 60 www.twitter.com otcadvisors 59 Genaera Corporation 59 WHICH ARE NOT PURELY 59 fibrosis IPF 59 PLAN OR EXPECT 59 www.combinatorx.com 59 HISTORICAL ARE FORWARD LOOKING 59 INFORMATION CONTAINED HEREIN 59 Barrier Therapeutics Inc. 59 By Neil Osterweil 59 Philadelphia PA eResearchTechnology 59 Staff Writer jschramm@minotdailynews.com 58 novel RNAi therapeutics 58 By Thomas Gryta 58 ADVENTRX Pharmaceuticals 58 Opexa Therapeutics Inc. 58 Inc. Nasdaq IMGN 58 www.syntapharma.com 58 Neurogen Corporation 58 YOUR OWN BLOG AD 58 Alseres Pharmaceuticals Inc. 58 Ltd. NASDAQ TSEM 58 microRNA therapeutics 58 STATEMENTS AND 58 Urigen Pharmaceuticals Inc. 58 inflammation autoimmune diseases 58 REED JR 58 Presents Positive 57 Fibrocell Science Inc. 57 R bortezomib 57 OR SIMILAR STATEMENTS ARE 57 biopharmaceutical 57 oncology therapeutics 57 Connetics Corporation 57 THE REPORTING 57 ViroPharma Incorporated 57 CA Somaxon Pharmaceuticals 57 involving hydrophilic liquid 57 AVEO Pharmaceuticals Inc. 57 UNITED STATES SECURITIES ACT 57 MYBA Announces Acquistion 57 optical biosensors 57 www.schering plough.com 57 kpender@sfchronicle.com 57 male hypogonadism licensed 57 addressing idiopathic pulmonary 57 PYMX 57 immunotherapeutics 57 Member CBOE NASD 57 novel antibody therapeutics 56 IN OTHER PUBLICLY 56 OF THE SUBSTANCE 56 http:/www.schering-plough.com 56 Powerwave Powerwave Technologies 56 commercial bioproduction 56 LIMITATION MAY NOT APPLY 56 Inc. NASDAQ CRIS 56 INVESTING IN SECURITIES INVOLVES 56 THE EXPRESSED WRITTEN CONSENT 56 Adherex Technologies Inc. 56 areas oncology endocrinology 56 Shamila Janakiraman 56 immunologic diseases 56 THE COMPANY INCLUDE BUT 56 Pharsight Corporation 56 www.facebook.com/pages/OTC-ADVISORS-LLC/#veejay 56 Tranzyme Pharma 56 Transcept Pharmaceuticals 56 therapeutic monoclonal antibodies 56 commercializing novel 56 mail newmedia@seattlepi.com mail 56 BioSpecifics Technologies Corp. 56 BioMarin develops 56 Cardium Therapeutics Inc. 56 By RYAN DEZEMBER 56 By GlobeNewswire #/#/# 56 WATERTOWN Mass. BUSINESS WIRE 56 Axxess Pharma Inc. 55 FREE MAIN LISTING SIGN 55 Adeona Pharmaceuticals Inc.